Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Costas Thomopoulos

Showing results (91-100 of 190) with videos related to

Pageof 19
Sort By:
Hepato-Gastroenterology|March 2, 2006
Sleep disorders and brain MRI as early indicators of subclinical hepatic encephalopathyDimitris Velissaris, Ekaterini Solomou, Andreas Kalogeropoulos, et al.
American Journal of Hypertension|September 4, 2025
Treatment targets for blood pressure lowering in patients with diabetes mellitusIoannis Vasileiadis, Aliki Zografou, Costas Platanias, et al.
American Journal of Nephrology|March 5, 2011
Comparative prognostic role of nighttime blood pressure and nondipping profile on renal outcomesCostas Tsioufis, Ioannis Andrikou, Costas Thomopoulos, et al.
Current Vascular Pharmacology|August 3, 2013
Renal and cardiac effects of renal sympathetic denervation and carotid baroreceptor stimulationCostas Tsioufis, Kyriakos Dimitriadis, Costas Thomopoulos, et al.
Pharmacological Research|August 2, 2020
Antidiabetic drugs and blood pressure changesIoannis Ilias, Costas Thomopoulos, Helena Michalopoulou, et al.
Hypertension (Dallas, Tex. : 1979)|June 18, 2025
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published StudiesGuido Grassi, Fosca Quarti-Trevano, Cesare Cuspidi, et al.
The Lancet. Diabetes & Endocrinology|November 25, 2022
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetesSverre E Kjeldsen, Mattias Brunström, Costas Thomopoulos, et al.
Pharmacological Research|September 21, 2021
Net clinical benefit of a reduced dose of DOACs in non-valvular atrial fibrillation: A meta-analysis of randomized trialsCostas Thomopoulos, John Ntalakouras, Dimitris Polyzos, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 3, 2009
Impaired glucose metabolism and the exaggerated blood pressure response to exercise treadmill testing in normotensive patientsMaria V Papavasileiou, Costas Thomopoulos, Ilias Antoniou, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 6, 2025
Heart failure with preserved ejection fraction and a systolic blood pressure target of 129 mmHg: are we on cloud nine?Ioannis Vasileiadis, Rafaella Paparidou, Andreas Papalysandrou, et al.
Pageof 19

Showing results (91-100 of 190) with videos related to

Sort By:
Pageof 19
Hepato-Gastroenterology|March 2, 2006
Sleep disorders and brain MRI as early indicators of subclinical hepatic encephalopathyDimitris Velissaris, Ekaterini Solomou, Andreas Kalogeropoulos, et al.
American Journal of Hypertension|September 4, 2025
Treatment targets for blood pressure lowering in patients with diabetes mellitusIoannis Vasileiadis, Aliki Zografou, Costas Platanias, et al.
American Journal of Nephrology|March 5, 2011
Comparative prognostic role of nighttime blood pressure and nondipping profile on renal outcomesCostas Tsioufis, Ioannis Andrikou, Costas Thomopoulos, et al.
Current Vascular Pharmacology|August 3, 2013
Renal and cardiac effects of renal sympathetic denervation and carotid baroreceptor stimulationCostas Tsioufis, Kyriakos Dimitriadis, Costas Thomopoulos, et al.
Pharmacological Research|August 2, 2020
Antidiabetic drugs and blood pressure changesIoannis Ilias, Costas Thomopoulos, Helena Michalopoulou, et al.
Hypertension (Dallas, Tex. : 1979)|June 18, 2025
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published StudiesGuido Grassi, Fosca Quarti-Trevano, Cesare Cuspidi, et al.
The Lancet. Diabetes & Endocrinology|November 25, 2022
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetesSverre E Kjeldsen, Mattias Brunström, Costas Thomopoulos, et al.
Pharmacological Research|September 21, 2021
Net clinical benefit of a reduced dose of DOACs in non-valvular atrial fibrillation: A meta-analysis of randomized trialsCostas Thomopoulos, John Ntalakouras, Dimitris Polyzos, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 3, 2009
Impaired glucose metabolism and the exaggerated blood pressure response to exercise treadmill testing in normotensive patientsMaria V Papavasileiou, Costas Thomopoulos, Ilias Antoniou, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 6, 2025
Heart failure with preserved ejection fraction and a systolic blood pressure target of 129 mmHg: are we on cloud nine?Ioannis Vasileiadis, Rafaella Paparidou, Andreas Papalysandrou, et al.
Pageof 19